← Back to Search

Educational Program for Breast Cancer Survivors

Led By Erica Warner, MPH, ScD
Research Sponsored by Massachusetts General Hospital
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks
Awards & highlights

Study Summary

This trial tests a 6-week online course to help Black breast cancer survivors with physical activity, goal setting, nutrition, sleep, stress, and social connections.

Who is the study for?
This trial is for Black or African American women aged 22-79 who have been diagnosed with Stage I, II, or III invasive breast cancer. Participants must have completed active treatment at least 6 months ago but within the last five years and speak English.Check my eligibility
What is being tested?
The study is testing a virtual education program tailored for Black breast cancer survivors. Over six weeks, it covers topics like physical activity, nutrition, goal setting, sleep management, stress reduction, and building social connections.See study design
What are the potential side effects?
Since this is an educational intervention focusing on lifestyle improvements and support rather than medical treatments or drugs, there are no direct side effects associated with typical clinical trials.


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Data collection feasibility
Proportion of Eligible Participants
Rate of Intervention Completion
+3 more
Secondary outcome measures
Dietary Behavior Goal Change
Intention to Receive post-treatment Surveillance Mammography
Physical Activity Goal Change
+2 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Breast Cancer Survivor Education ProgramExperimental Treatment1 Intervention
Participants will complete study procedures as outlined: - 6 weekly sessions of a modified version of the PAVING the Path to Wellness education program.

Find a Location

Who is running the clinical trial?

PfizerIndustry Sponsor
4,578 Previous Clinical Trials
10,923,462 Total Patients Enrolled
111 Trials studying Breast Cancer
35,852 Patients Enrolled for Breast Cancer
Massachusetts General HospitalLead Sponsor
2,941 Previous Clinical Trials
13,200,653 Total Patients Enrolled
80 Trials studying Breast Cancer
132,883 Patients Enrolled for Breast Cancer
American Cancer Society, Inc.OTHER
224 Previous Clinical Trials
110,440 Total Patients Enrolled
32 Trials studying Breast Cancer
8,869 Patients Enrolled for Breast Cancer

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any vacancies that participants can join in this clinical research?

"Data hosted on clinicaltrials.gov affirms that enrollment for this particular trial was closed as of January 17th 2023 and is no longer accepting patients at the moment. Despite this, there are currently over 2500 other studies actively recruiting participants."

Answered by AI

What purposes does this trial seek to achieve?

"According to the Pfizer-sponsored trial, their primary endpoint is Time Required to Recruit to Target and will be monitored over a 6 week period. Additionally, secondary outcomes being observed include Intention to Receive post-treatment Surveillance Mammography (via FOCUS Survey), Physical Activity Goal Change (also via FOCUS Survey) and Dietary Behavior Goal Change (again with the help of the FOCUS survey)."

Answered by AI
~7 spots leftby May 2025